Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitamin D3 Supplementation for Symptomatic Uterine Fibroids
NCT07012161Phase 1Recruiting
- Start
- Feb 2025
- Primary completion
- Sep 2026
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of vitamin d in Uterine Fibroids (UF). Primary endpoint: Effect of Vitamin D3 supplementation on symptomatic uterine fibroid at 18 months. Started Feb 2025; status: recruiting.
02
Drugs
vitamin d
03
Conditions
Uterine Fibroids (UF)
Beyond the preview
Go deeper on NCT07012161.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07012161.